To provide services on High throughput genomics, transcriptomics, metagenomics and proteomics. To provide services, consultancy and training on clinical genomics for both academic research as well as clinical diagnosis purpose. Consultancy and services would be on state of art technologies involving next generation sequencing (DNA-seq, RNA-seq, CHIP-seq), Peptide synthesis, post sequencing data analysis, interpretation. To strive on transforming biomedical research ?to be Artificial intelligence driven? based on genomics data.

Research and development

Source: Ministry of Corporate Affairs company master (open data). Capital figures are as-of the 2021 registry snapshot, not live.